Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future

By  

Current Medicinal Chemistry, Vol. 18, Iss. 7, 2011-03 ,pp. : 1038-1049

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3142-3154

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 553-574

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3248-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite